Nasdaq · CIK 0001613780
DBVT DBV Technologies S.A.
Insider trading from SEC Form 4. Last filing Mar 31, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
4
with a Form 4 at this company
Signals
Open-market buys and sells at DBV Technologies S.A., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 15Weak | sell | Mohideen Pharis Chief Medical Officer | $510 | 600 | -1% | - | |
| 15Weak | sell | Mohideen Pharis Chief Medical Officer | $503 | 907 | -1% | - | |
| 15Weak | sell | Mohideen Pharis Chief Medical Officer | $1,269 | 2,350 | -2% | - |
Transactions
The last 13 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | BAKER BROS. ADVISORS LP director, owner | AGrant or award First Pre-Funded Warrantderivativeindirect: See Footnotes | +2,299,656 | - | - | 2,299,656 | Mar 31, 2025 |
| Mar 27, 2025 | BAKER BROS. ADVISORS LP director, owner | AGrant or award First Pre-Funded Warrantderivativeindirect: See Footnotes | +25,005,240 | - | - | 25,005,240 | Mar 31, 2025 |
| Mar 27, 2025 | BAKER BROS. ADVISORS LP director, owner | AGrant or award BS Warrantderivativeindirect: See Footnotes | +2,299,656 | - | - | 2,299,656 | Mar 31, 2025 |
| Mar 27, 2025 | BAKER BROS. ADVISORS LP director, owner | AGrant or award BS Warrantderivativeindirect: See Footnotes | +25,005,240 | - | - | 25,005,240 | Mar 31, 2025 |
| Jan 30, 2025 | Mohideen Pharis Chief Medical Officer | SOpen-market sale Ordinary Shares | -600 | $0.85 | $510 | 110,510 | Jan 31, 2025 |
| Dec 4, 2024 | Tasse Daniel CHIEF EXECUTIVE OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +813,200 | $0.00 | $0 | 813,200 | Dec 5, 2024 |
| Nov 22, 2024 | Mohideen Pharis Chief Medical Officer | SOpen-market sale Ordinary Shares | -342 | $0.53 | $181 | 111,675 | Nov 27, 2024 |
| Nov 25, 2024 | Mohideen Pharis Chief Medical Officer | SOpen-market sale Ordinary Shares | -565 | $0.57 | $322 | 111,110 | Nov 27, 2024 |
| Nov 21, 2024 | Boucinha Virginie Chief Financial Officer | AGrant or award Ordinary Shares | +19,000 | $0.00 | $0 | 38,000 | Nov 25, 2024 |
| Nov 21, 2024 | Mohideen Pharis Chief Medical Officer | AGrant or award Ordinary Shares | +35,000 | $0.00 | $0 | 114,367 | Nov 25, 2024 |
| Nov 21, 2024 | Boucinha Virginie Chief Financial Officer | AGrant or award Employee Stock Option (right to buy)derivative | +113,000 | $0.00 | $0 | 113,000 | Nov 25, 2024 |
| Nov 21, 2024 | Mohideen Pharis Chief Medical Officer | SOpen-market sale Ordinary Shares | -2,350 | $0.54 | $1,269 | 112,017 | Nov 25, 2024 |
| Nov 21, 2024 | Mohideen Pharis Chief Medical Officer | AGrant or award Employee Stock Option (right to buy)derivative | +215,000 | $0.00 | $0 | 215,000 | Nov 25, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- BAKER BROS. ADVISORS LPdirector, owner
- Boucinha VirginieChief Financial Officer
- Mohideen PharisChief Medical Officer
- Tasse DanielCHIEF EXECUTIVE OFFICER
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.